The danger of ‘yellow dyes’ (tartrazine) to allergic subjects
- 1 January 1978
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 8 (1) , 65-68
- https://doi.org/10.1111/j.1365-2222.1978.tb00449.x
Abstract
Summary: Oral administration of 50 mg tartrazine to 122 patients with a variety of allergic disorders caused the following reactions: general weakness, heatwaves, palpitations, blurred vision, rhinorrhoea, feeling of suffocation, pruritus and urticaria.There was activation of the fibrinolytic pathway as shown by reduction of plas‐minogen with high pre‐kallikrein and low kallikrein values. Reduction in complement activity (CH50) was seen in three out of sixteen reactions.This publication has 11 references indexed in Scilit:
- Drugs containing tartrazine dyeJournal of Allergy and Clinical Immunology, 1976
- Significance of tartrazine sensitivity in chronic urticaria of unknown etiologyJournal of Allergy and Clinical Immunology, 1976
- Oral bronchodilators containing tartrazinePublished by American Medical Association (AMA) ,1976
- Hypersensitivity to acetylsalicylic acid (ASA) and tartrazine in patients with asthmaClinical and Experimental Allergy, 1976
- The prevalence of immediate positive skin tests to Dermatophagoides pteronyssinus and grass pollen in schoolchildrenClinical and Experimental Allergy, 1976
- Atopy reconsidered*Clinical and Experimental Allergy, 1976
- Urticaria induced by preservatives and dye additives in food and drugsBritish Journal of Dermatology, 1973
- The Kallikreinogen-Kallikrein Enzyme System of Human PlasmaAnnals of Internal Medicine, 1969
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965
- Immunochemical quantitation of antigens by single radial immunodiffusionMolecular Immunology, 1965